Inovio Pharmaceuticals, Inc. (INO)
2.055
-0.08
(-3.52%)
USD |
NASDAQ |
Dec 12, 16:00
2.07
+0.02
(+0.73%)
After-Hours: 16:16
Inovio Pharmaceuticals Research and Development Expense (TTM): 55.38M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Agenus, Inc. | 105.60M |
| Perspective Therapeutics, Inc. | 61.22M |
| Arcturus Therapeutics Holdings, Inc. | 101.81M |
| Capricor Therapeutics, Inc. | 74.99M |
| Myomo, Inc. | 6.879M |